NeuroSense Therapeutics

/NeuroSense Therapeutics

IPO

NeuroSense Therapeutics

Biotechnology

Our goal is to develop therapeutics to defeat neurodegenerative diseases. We are a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases.

Symbol

NRSN

Price Range
$6.00 - $7.00

Final Shares
1,846,154

Anticipated Date
December 9, 2021

Underwriters
MAXIM GROUP LLC

This offering is no longer available

To view the prospectus for NeuroSense Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange